The Transfusion News email arrived today:
Transfusion of Red Blood Cells from Younger Donors Is Not Associated with Improved Survival
![]()
April 26, 2017
Animal models suggest that blood from younger donors may provide revitalizing benefits, but findings from observational cohort studies on this topic have been inconsistent. Investigators in Scandinavia recently performed a retrospective cohort study following 968,264 red blood cell (RBC) transfusion recipients for 10 years. Since multiple transfusions can confound results, researchers used multiple approaches to [Read More]
Animal models suggest that blood from younger donors may provide revitalizing benefits, but findings from observational cohort studies on this topic have been inconsistent. Investigators in Scandinavia recently performed a retrospective cohort study following 968,264 red blood cell (RBC) transfusion recipients for 10 years. Since multiple transfusions can confound results, researchers used multiple approaches to [Read More]
Stored Whole Blood Treated with Pathogen Reduction Acceptable for Transfusion
Pathogen reduction technology (PRT) hold promise for eliminating many known and emerging pathogens in donated blood and thus preventing transfusion transmission. The performance of the Mirasol system, which uses a combination of riboflavin and ultraviolet light to inactivate pathogens and any remaining white blood cells, was recently tested on whole blood (WB) in a two-center [Read More]
Prophylactic Platelet Transfusions are Not Superior to Supportive Care for Dengue Patients with Thrombocytopenia
According to the World Health Organization, the incidence of dengue has increased 30-fold in the past 50 years, and over half of the world’s population is at risk of infection. Acute infection with dengue virus typically causes flu-like symptoms, but can also be associated with severe bleeding and thrombocytopenia. In order to determine if prophylactic [Read More]
No comments:
Post a Comment